Overview of DS TMD and DS AMKL samples analyzed by exome sequencing and SNP microarray
Patient . | Diagnosis . | Chr21 . | GATA1 sequence . | SNP microarray . | SCNA gain . | SCNA loss . | Exome sequence . | Putative third-hit driver event? . |
---|---|---|---|---|---|---|---|---|
TMD1 | TMD | Trisomy | p.S12Fs | Yes | No | |||
TMD2 | TMD | Trisomy | p.50_61ins | Yes | No | |||
TMD3 | TMD | Trisomy | p.F34Fs; P.51_56ins | Yes | Yes | No | ||
TMD4 [= AMKL4] | TMD | Trisomy | p.58_64ins; p.71_74del | Yes | Yes | Yes (PIK3C2A) | ||
TMD5 | TMD | Trisomy | p.V77Fs | Yes | No | |||
TMD8 | TMD | Trisomy | p.G31Fs | Yes | No | |||
TMD10 | TMD | Trisomy | p.E13× | Yes | Yes | No | ||
TMD11 | TMD | Trisomy | p.G7Fs | Yes | No | |||
TMD12 | TMD | Trisomy | splicing 5′ exon 2 | Yes | Yes | Yes (FLT3) | ||
TMD14 | TMD | Trisomy | P.V74I (exon2 3′ splice site) | Yes | Yes | No | ||
AMKL4 [= TMD4] | AML-M7 | Trisomy | p.71_74del | Yes | Chr5 1.3-3.7, 87-122 | Yes | Yes (EZH2, SMC3, DHX29, APC) | |
AMKL15 | AML-M7 | Tetrasomy | p.Y62Fs (dupl) | Yes | Chr14 tetrasomy 19.5-106.3 | Chr8 113.1-119.3 | Yes | Yes (DLEC1, EXT1) |
AMKL15rem | Remission | Trisomy | wt | Yes | Yes | No | ||
AMKL16 | AML-M7 | Trisomy | p.52_58ins | Yes | Chr7 q-arm | Chr3 60.2-60.9, 153.4-153.6, 176.2-176.8, Chr6 161.9-162.9, Chr7 p-arm | Yes | Yes (JAK1, POLE, PARK2-PACRG) |
AMKL16rem | Remission | Trisomy | wt | Yes | Yes | No | ||
AMKL20 | AML-M7 | Trisomy | p.P50Fs | Yes | Chr1 174-247, Chr15 62-99.5 | Chr7 0-10.1 | (SCNAs seen in leukemias) | |
AMKL21 | AML-M7 | Trisomy | p.F33Fs | Yes | Chr1 200-247 | Chr17 0-7.7, 75.9-77.3 | (SCNAs seen in leukemias) | |
AMKL24 | AML-M7 | Trisomy | p.P50Fs | Yes | Chr1 222-247 | (SCNAs seen in leukemias) | ||
AMKL25 | AML-M7 | Trisomy | p.T52Fs (dupl) | Yes | t(X;16)(q26;q23) (associated with multiple myeloma) |
Patient . | Diagnosis . | Chr21 . | GATA1 sequence . | SNP microarray . | SCNA gain . | SCNA loss . | Exome sequence . | Putative third-hit driver event? . |
---|---|---|---|---|---|---|---|---|
TMD1 | TMD | Trisomy | p.S12Fs | Yes | No | |||
TMD2 | TMD | Trisomy | p.50_61ins | Yes | No | |||
TMD3 | TMD | Trisomy | p.F34Fs; P.51_56ins | Yes | Yes | No | ||
TMD4 [= AMKL4] | TMD | Trisomy | p.58_64ins; p.71_74del | Yes | Yes | Yes (PIK3C2A) | ||
TMD5 | TMD | Trisomy | p.V77Fs | Yes | No | |||
TMD8 | TMD | Trisomy | p.G31Fs | Yes | No | |||
TMD10 | TMD | Trisomy | p.E13× | Yes | Yes | No | ||
TMD11 | TMD | Trisomy | p.G7Fs | Yes | No | |||
TMD12 | TMD | Trisomy | splicing 5′ exon 2 | Yes | Yes | Yes (FLT3) | ||
TMD14 | TMD | Trisomy | P.V74I (exon2 3′ splice site) | Yes | Yes | No | ||
AMKL4 [= TMD4] | AML-M7 | Trisomy | p.71_74del | Yes | Chr5 1.3-3.7, 87-122 | Yes | Yes (EZH2, SMC3, DHX29, APC) | |
AMKL15 | AML-M7 | Tetrasomy | p.Y62Fs (dupl) | Yes | Chr14 tetrasomy 19.5-106.3 | Chr8 113.1-119.3 | Yes | Yes (DLEC1, EXT1) |
AMKL15rem | Remission | Trisomy | wt | Yes | Yes | No | ||
AMKL16 | AML-M7 | Trisomy | p.52_58ins | Yes | Chr7 q-arm | Chr3 60.2-60.9, 153.4-153.6, 176.2-176.8, Chr6 161.9-162.9, Chr7 p-arm | Yes | Yes (JAK1, POLE, PARK2-PACRG) |
AMKL16rem | Remission | Trisomy | wt | Yes | Yes | No | ||
AMKL20 | AML-M7 | Trisomy | p.P50Fs | Yes | Chr1 174-247, Chr15 62-99.5 | Chr7 0-10.1 | (SCNAs seen in leukemias) | |
AMKL21 | AML-M7 | Trisomy | p.F33Fs | Yes | Chr1 200-247 | Chr17 0-7.7, 75.9-77.3 | (SCNAs seen in leukemias) | |
AMKL24 | AML-M7 | Trisomy | p.P50Fs | Yes | Chr1 222-247 | (SCNAs seen in leukemias) | ||
AMKL25 | AML-M7 | Trisomy | p.T52Fs (dupl) | Yes | t(X;16)(q26;q23) (associated with multiple myeloma) |
dupl, duploid; wt, wild type.